List of insiders holdings for Eiger BioPharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | KAYNE RICHARD A 10% Owner |
2023-11-02 21:21:30 | 0 5,375,225 |
5,375,225 | Form 4 |
| 2 | KAWAS LEEN 10% Owner |
2023-11-02 21:14:42 | 0 4,391,432 |
4,391,432 | Form 4 |
| 3 | Kordel Johan Director |
2014-02-06 15:44:42 | 0 1,774,349 |
1,774,349 | Form 4 |
| 4 | ZSEBO KRISZTINA M Chief Executive Officer |
2015-04-07 16:38:03 | 1,301,188 0 |
1,301,188 | Form 4 |
| 5 | Foley Todd Director |
2014-02-06 16:30:32 | 0 1,084,292 |
1,084,292 | Form 4 |
| 6 | INTERWEST PARTNERS X LP InterWest Management Partners X LLC Kliman Gilbert H ORONSKY ARNOLD L Desai Keval NASR KHALED 10% Owner |
2019-02-06 16:08:01 | 935,428 0 |
935,428 | Form 13D |
| 7 | INTERWEST PARTNERS X LP InterWest Management Partners X LLC CLEVELAND BRUCE A GIANOS PHILIP T Holmes W Stephen Kliman Gilbert H ORONSKY ARNOLD L Desai Keval NASR KHALED 10% Owner |
2019-02-06 16:08:01 | 935,428 0 |
935,428 | Form 13D |
| 8 | Apelian David CEO |
2023-07-06 17:37:37 | 750,000 0 |
750,000 | Form 4 |
| 9 | Cory David A President and CEO |
2022-03-11 21:06:19 | 450,183 0 |
450,183 | Form 4 |
| 10 | EcoR1 Capital LLC 10% Owner |
2020-02-14 14:29:18 | 449,338 0 |
449,338 | Form 13G |
| 11 | Cleveland Paul B President and CFO |
2015-01-05 20:51:16 | 417,500 0 |
417,500 | Form 4 |
| 12 | LABA REBECQUE J VP, Corporate Operations |
2015-04-03 16:12:17 | 305,359 0 |
305,359 | Form 4 |
| 13 | WIKLUND FREDRIK See Remarks |
2015-01-05 20:36:27 | 216,368 0 |
216,368 | Form 4 |
| 14 | RUDY JEFFREY J VP, Clinical Operations |
2015-01-12 18:28:05 | 182,762 0 |
182,762 | Form 4 |
| 15 | REED ELIZABETH E VP, General Counsel |
2015-01-05 20:44:47 | 142,669 0 |
142,669 | Form 4 |
| 16 | TAKEYA RYAN K VP, Manufacturing |
2015-04-03 16:09:13 | 141,006 0 |
141,006 | Form 4 |
| 17 | PFIZER INC 10% Owner |
2016-04-04 16:14:49 | 121,899 0 |
121,899 | Form 13G |
| 18 | Vollins James General Counsel |
2023-05-02 16:30:36 | 120,000 0 |
120,000 | Form 4 |
| 19 | Shaffer James P Chief Business Officer |
2021-03-15 19:41:10 | 100,546 0 |
100,546 | Form 4 |
| 20 | Patton Stephana Eilene See Remarks |
2021-03-15 19:36:03 | 89,198 0 |
89,198 | Form 4 |
| 21 | WELCH JAMES H Chief Financial Officer |
2018-03-16 20:14:23 | 60,000 0 |
60,000 | Form 4 |
| 22 | Mayer Eldon C. III Ex VP & Chief Commerc. Officer |
2023-03-21 21:00:25 | 56,073 0 |
56,073 | Form 4 |
| 23 | Choong Ingrid Chief Business Officer |
2023-09-05 21:38:59 | 54,000 0 |
54,000 | Form 4 |
| 24 | NARACHI MICHAEL Director |
2015-06-05 18:26:34 | 50,000 0 |
50,000 | Form 4 |
| 25 | Ryali Sriram Chief Financial Officer |
2022-03-14 21:22:50 | 41,566 0 |
41,566 | Form 4 |
| 26 | COOPER GRAHAM K Director |
2015-06-05 18:24:48 | 40,000 0 |
40,000 | Form 4 |
| 27 | Dietz Thomas John Director |
2023-03-03 20:49:50 | 40,000 0 |
40,000 | Form 4 |
| 28 | Alton Gregg H Director |
2015-06-05 18:24:03 | 40,000 0 |
40,000 | Form 4 |
| 29 | Jackson Andrew C. See Remarks |
2015-03-17 20:10:21 | 36,437 0 |
36,437 | Form 3 |
| 30 | Martins Eduardo Bruno SVP, Liver and Infectious Dise |
2017-03-14 19:33:46 | 30,000 0 |
30,000 | Form 4 |
| 31 | Sablich Kim Director |
2023-03-03 20:50:03 | 28,000 0 |
28,000 | Form 4 |
| 32 | Kelly-Croswell Lisa Director |
2023-03-03 20:49:57 | 28,000 0 |
28,000 | Form 4 |
| 33 | Glenn Jeffrey S Director |
2023-03-03 20:50:10 | 28,000 0 |
28,000 | Form 4 |
| 34 | Murray Christine Director |
2023-03-03 20:50:16 | 28,000 0 |
28,000 | Form 4 |
| 35 | Loh Evan Director |
2023-03-03 20:50:26 | 28,000 0 |
28,000 | Form 4 |
| 36 | Sachdev Amit Director |
2023-03-03 20:50:28 | 28,000 0 |
28,000 | Form 4 |
| 37 | Atkisson Erik GC & Chief Compliance Officer |
2023-01-30 21:15:13 | 26,750 0 |
26,750 | Form 4 |
| 38 | Honig Peter Director |
2015-06-05 18:25:54 | 22,800 0 |
22,800 | Form 4 |
| 39 | Quan Joanne Chief Medical Officer |
2018-04-04 17:18:58 | 22,256 0 |
22,256 | Form 4 |
| 40 | ENGLEMAN EDGAR Director 10% Owner |
2017-04-13 19:12:51 | 10,000 0 |
10,000 | Form 4 |
| 41 | Kjellson Nina S Director |
2017-04-14 14:32:05 | 10,000 0 |
10,000 | Form 4 |
| 42 | Bramlage Charles Director |
2017-04-13 19:23:26 | 10,000 0 |
10,000 | Form 4 |
| 43 | Yang Patrick Y Director |
2014-05-21 16:17:37 | 10,000 0 |
10,000 | Form 4 |
| 44 | Funder Joshua Director |
2014-05-21 16:14:50 | 10,000 0 |
10,000 | Form 4 |
| 45 | Vivo Ventures VI LLC Vivo Ventures Fund VI L.P. VIVO VENTURES VI AFFIILATES FUND L.P. 10% Owner |
2022-02-11 17:23:02 | 4,166 0 |
4,166 | Form 13D |
| 46 | RA CAPITAL MANAGEMENT LLC Kolchinsky Peter RA Capital Healthcare Fund LP 10% Owner |
2020-02-14 16:34:18 | 0 0 |
0 | Form 13G |
| 47 | Dalton Barbara Director |
2014-01-29 19:37:58 | 0 0 |
0 | Form 3 |
| 48 | Kachioff William G CFO |
2023-04-14 18:42:03 | 0 0 |
0 | Form 3 |
| 49 | Novartis Bioventures Ltd 10% Owner |
2016-01-07 16:05:30 | 0 0 |
0 | Form 13G |
| 50 | Lundbeckfond Invest A/S 10% Owner |
2016-01-29 07:27:36 | 0 0 |
0 | Form 13G |
| 51 | Enterprise Partners Management LLC 10% Owner |
2016-01-05 16:01:43 | 0 0 |
0 | Form 13G |
| 52 | Enterprise Partners Management LLC Enterprise Partners Liquidating Trust V Enterprise Partners Liquidating Trust VI 10% Owner |
2016-01-05 16:01:43 | 0 0 |
0 | Form 13G |